Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN70634383
ISRCTN70634383
Active, Not Recruiting
Phase 3

Clinical and laboratory evaluation of the efficiency of preconditioning with photobiomodulation in preventing chemotherapy-induced oral mucositis

Damascus University0 sites45 target enrollmentJuly 24, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPrevention of oral mucositis? in chemotherapy-treated cancer patientsOral Health

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Prevention of oral mucositis? in chemotherapy-treated cancer patients
Sponsor
Damascus University
Enrollment
45
Status
Active, Not Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 24, 2023
End Date
February 18, 2024
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Cancer patients undergoing chemotherapy for the first time with the same risk of mucositis:
  • •1\. Solid tumor patients
  • •1\.1\. Chemotherapy (5\-Fluorouracil) intravenously or orally
  • •1\.2\. Neutrophil count \= 1500 cells/µL
  • •1\.3\. Platelet count \= 100,000/µl
  • •1\.4\. A healthy oral mucosa
  • •1\.5\. Karnofsky performance status index \>60

Exclusion Criteria

  • •1\. Radiotherapy in the head and neck area
  • •2\. Malignant or potentially malignant lesions of the oral cavity
  • •3\. Oral infections
  • •4\. Oral bleeding
  • •5\. Undergoing any other measures to prevent oral mucositis
  • •6\. Patients unable to commit to the study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
N/A
Comparison of 2 New Locally Acting Medicaments in Periodontal Pockets in Patients with Gum Disorder
CTRI/2019/08/020651Dr Nikita Patil10
Not Yet Recruiting
Phase 3
Comparing the efficacy of two different formulations of tetracycline antibiotic when applied locally in patients with gum diseaseHealth Condition 1: K053- Chronic periodontitis
CTRI/2024/05/067595Mala Dixit Baburaj Primary Investigator
Not Yet Recruiting
Phase 2
Evaluation of the efficacy of Siddha classical decoction formulation Aavarai Kudineer in management of Diabetic NephropathyHealth Condition 1: E112- Type 2 diabetes mellitus with kidney complications
CTRI/2024/04/065467ot Applicable
Not Yet Recruiting
Phase 3
Effect of Ayurvedic Eye Treatment in Diabetic RetinopathyHealth Condition 1: H36- Retinal disorders in diseases classified elsewhere
CTRI/2022/10/046903ational Institute of Ayurveda Jaipur
Not Yet Recruiting
Phase 2
Effect of Tab HF-PRT01 in Piles
CTRI/2019/04/018662SIDDHAYU AYURVEDIC RESEARCH FOUNDATIO